Abstract:Background The etiopathogenesis of major depressive disorder(MDD)is strongly associated with neuroinflammation.MDD is a highly heterogeneous psychiatric disorder,and the disease subtyping is an essential step for the identification of biological markers.The presence of psychomotor retardation seriously affects the prognosis of MDD,whereas the underlying mechanism is not yet completely clear.A potential involvement of granulocyte colony-stimulating factor(G-CSF)and macrophage colony-stimulating factor(M-CSF)in the pathogenesis of MDD with psychomotor retardation has been suggested in previous studies,but little detailed research has been completed.Objective To analyze the correlation of plasma G-CSF and M-CSF levels with psychomotor retardation in patients with MDD,and to explore the potential biological underpinnings of psychomotor retardation in MDD.Methods A total of 50 MDD patients who met the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders,fifth edition(DSM-5)and attended the outpatient clinics of Shanghai Mental Health Center from April 2018 to April 2019 were included.The severity of symptoms was assessed using the Hamilton Depression Scale-17 item(HAMD-17).According to the retardation factor in HAMD-17,patients with a score of≥8 were included in retardation group(n=22),and those with a score below 8 were included in non-retardation group(n=28).Another 22 age-and sex-matched healthy controls were concurrently recruited.Plasma G-CSF and M-CSF levels were measured in all subjects using Luminex liquid suspension chip technology.Spearman correlation analysis was adopted to verify the correlation of retardation factor score in HAMD-17 with plasma G-CSF and M-CSF levels in MDD patients.Results Plasma G-CSF levels were decreased in MDD patients compared with healthy controls[57.34(39.24,83.15)pg/mL vs.71.47(61.20,79.99)pg/mL,Z=-2.098,P＜0.05].A statistical difference was found in plasma G-CSF level[63.92(54.60,89.43)pg/mL vs.47.80(33.41,74.66)pg/mL vs.71.47(61.20,79.99)pg/mL,H=8.247,P= 0.016]and plasma M-CSF level[20.05(16.05,22.23)pg/mL vs.13.05(11.43,17.50)pg/mL vs.18.95(14.59,22.88)pg/mL,H=7.620,P=0.022]among retardation group,non-retardation group and healthy control group.The post hoc pairwise comparisons using Bonferroni correction indicated that plasma G-CSF level was lower in non-retardation group compared with healthy control group(adjusted P＜0.05),and plasma M-CSF level was higher in retardation group compared with non-retardation group(adjusted P＜0.05).The retardation factor score in HAMD-17 was positively correlated with plasma M-CSF level in MDD patients(r=0.348,P＜0.05).Conclusion The prevalence of psychomotor retardation in MDD patients may be related to abnormally elevated plasma M-CSF level.

Low VGF is Associated with Executive Dysfunction in Patients with Major Depressive Disorder

Reduced Serum VGF Levels Were Reversed by Antidepressant Treatment in Depressed Patients

Higher Serum VGF Protein Levels Discriminate Bipolar Depression from Major Depressive Disorder

Plasma metabolites were associated with spatial working memory in major depressive disorder

Altered Fractional Amplitude of Low Frequency Fluctuation Associated with Cognitive Dysfunction in First-Episode Drug-Naïve Major Depressive Disorder Patients

Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD

In vivo evidence of increased vascular endothelial growth factor in patients with major depressive disorder

Larger regional white matter volume is associated with executive function deficit in remitted geriatric depression: an optimized voxel-based morphometry study.

Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy Controls

Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder

Increased Mir-132 Level is Associated with Visual Memory Dysfunction in Patients with Depression

Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder

The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder

Correlation of Psychomotor Retardation with Plasma G-CSF and M-CSF Levels in Patients with Major Depressive Disorder

Association Between Cognitive Function and Performance on Effort Based Decision Making in Patients with Major Depressive Disorder Treated with Vortioxetine.

Exploration of Major Cognitive Deficits in Medication-Free Patients with Major Depressive Disorder

The Relationship between Level of BDNF in Serum and Depressive Symptoms and Cognitive Dysfunction of Patients with Major Depression

Association Study Between Plasma GDNF and Cognitive Function in Late-Onset Depression.

Effect of Treatment on Serum Glial Cell Line-Derived Neurotrophic Factor in Bipolar Patients

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Glycosylation state of vWF in circulating extracellular vesicles serves as a novel biomarker for predicting depression.